In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

European pharmaceutical stocks slumped, continuing a selloff that started with US-listed peers after President Donald Trump ...

President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an ...

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The dividend will be paid on September 12, 2025, to all stockholders ...

On July 24, 2025, the PTO Acting Director Coke Morgan Stewart discretionarily denied Amgen’s IPR2025-00601 and IPR2025-00602 challenging ...

With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater ...

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

While the Trump administration tries to pressure drug companies to lower prices, it has also spent months threatening tariffs ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...